New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
16:30 EDTS, CLWR, CBOU, VVUS, CPWR, ENDOn The Fly: Closing Wrap
Stocks on Wall Street finished higher on the day after news out of Washington indicated that compromise on some of the most contentious elements of the fiscal cliff negotiations may be nearing. President Obama and House Speaker John Boehner met for 45 minutes today in Washington after a Washington Post report over the weekend said that the Obama administration had rejected Boehner's most recent offer. The averages opened the session higher and maintained their gains through the day, closing at their highs... ECONOMIC EVENTS: In the U.S., a benchmark for New York state manufacturing, the New York Fed's Empire State Survey, came up negative for a fifth straight month. The December reading, which was forecast to move up to -1.0 from its prior -5.2 level, instead slid to -8.10. In Europe, data showed euro zone exports declined 1.4% in October from the prior month, as imports increased 0.6%. In Asia, Japan elected a new prime minister who has vowed to adopt a large stimulus package, cut interest rates and take other measures to revive growth in the nation's economy... COMPANY NEWS: Sprint (S) struck a deal to acquire the approximately 50% stake in Clearwire (CLWR) it does not already own for $2.97 per share, or $2.2B. Shares of Clearwire traded lower following the news, closing down 47c, or 13.95%, to $2.90, while shares of Sprint were virtually flat on the session, closing up 1c, or 0.18%, to $5.56...MAJOR MOVERS: Among the notable gainers was Caribou Coffee (CBOU), up $3.78,or 30.68%, to $16.10 after agreeing to be acquired by Germany's Joh. A. Benckiser for $16.00 per share in cash, or $340M. Also higher were shares of VIVUS (VVUS), up $1.60, or 13.89%, to $13.07 after a report that prescriptions of the company's weight loss drug Qsymia rose 46% for the weekend ended November 12. Also higher were shares of Compuware (CPWR), up $1.22, or 12.80%, to $10.75 after Elliott Management offered to acquire the company for $11.00 per share in cash, or $2.3B. Among the noteworthy losers was Endeavour (END), which fell $1.11, or 17.62%, to $5.19 after research firm Global Hunter downgraded the stock to Accumulate from Buy and cut its price target on shares to $9 from $13... INDICES: The Dow was up 100.38, or 0.76%, to 13,235.39; the S&P 500 was up 16.78, or 1.19%, to 1,430.36; the Nasdaq was up 39.27, or 1.32%, to 3,010.60.
News For S;CLWR;CBOU;VVUS;CPWR;END From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
07:20 EDTSDeutsche Bank to hold a conference
Subscribe for More Information
September 30, 2014
07:53 EDTSAnalysts see AT&T with early lead over Verizon in connected cars, Reuters says
Subscribe for More Information
September 29, 2014
12:18 EDTSOn The Fly: Midday Wrap
Subscribe for More Information
10:32 EDTSDreamWorks jumps after report of Softbank takeover talks
Subscribe for More Information
September 26, 2014
05:50 EDTSStocks with implied volatility movement; TMUS S
Subscribe for More Information
September 19, 2014
07:36 EDTSSprint price target cut to $8-$10 from $11-$11.75 at Wells Fargo
Subscribe for More Information
September 18, 2014
16:27 EDTVVUSOn The Fly: Closing Wrap
Subscribe for More Information
14:09 EDTVVUSVIVUS rallies, mean-reverting to intraday trend line
The shares have traded in an extremely wide range today on nearly 20 times daily average volume. An intraday trend line appears currently to be broken. That line is at $4.60 now, and projecting forward would be at the $4.80 area by the close. At the current price of $4.50, support is at $4.41 and then at $4.32.
12:45 EDTVVUSOn The Fly: Midday Wrap
Subscribe for More Information
09:36 EDTVVUSActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
08:59 EDTVVUSOn The Fly: Pre-market Movers
Subscribe for More Information
07:55 EDTENDEndeavour receives notice of non-compliance with NYSE listing standards
Endeavour has been notified by the NYSE that it is not in compliance with two of the NYSE's continued listing standards. The NYSE requires that the average closing price per share of a listed company's stock be in excess of $1.00 for a consecutive 30-trading day period. Under this continued listing criteria, Endeavour has a period of six months, subject to possible extension, to bring its average share price back over $1.00. The company's common stock expects to be listed and traded on the NYSE during this period. In addition, the company's total market capitalization has averaged less than $50M over a consecutive 30 trading-day period and its last reported shareholders' equity was also below $50M. Endeavour has 45-days from receipt of the NYSE notice to submit a business plan to the NYSE demonstrating how it intends to comply with the NYSE's continued listing standards. The company's stock expects to trade on the NYSE during the plan period.
06:05 EDTVVUSVIVUS, Auxilium announce FDA approval of STENDRA sNDA
VIVUS (VVUS) and Auxilium Pharmaceuticals (AUXL) announced that the FDA has approved a supplemental new drug application, or sNDA, for STENDRA. STENDRA is now the only FDA-approved erectile dysfunction, or ED, medication indicated to be taken as early as approximately 15 minutes before sexual activity. STENDRA is a prescription medication in a class of drugs known as phosphodiesterase type 5, or PDE5, inhibitors approved for the treatment of ED in men 18 years or older. STENDRA is available in multiple dosage strengths and may be taken with or without food and moderate alcohol consumption. In clinical studies, when compared to placebo, STENDRA helped more men achieve an erection in as early as approximately 15 minutes that lasted long enough to successfully complete sexual intercourse.
September 17, 2014
12:53 EDTSSprint management to meet with Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use